Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Heartburn & Stomach Medication Recalls

Recalls of acid reducers and stomach drugs - the class behind the ranitidine (Zantac) nitrosamine recalls.

211 recalls in this category, newest first.

Class III · Low risk

Famotidine tablets

Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances -impurity 8 at 24 month stability interval.

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-118-30 D-0009-2018
Class II · Moderate risk

Famotidine USP 20 mg

Failed Tablet/Capsule Specification: out of specification for tablet weight.

Terminated Failed specification PD-Rx Pharmaceuticals, Inc. NDC 55289-765-30 D-1057-2017
Class II · Moderate risk

Famotidine Tablets USP

Failed Tablet/Capsule Specification; out of specification for tablet weight

Terminated Failed specification Teva Pharmaceuticals USA NDC 0172-5728-60 D-1056-2017
Class II · Moderate risk

Famotidine HCl all strengths

Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Terminated Labeling / mix-up Advanced Pharma Inc. D-0842-2017
Class III · Low risk

Protonix I.V.

Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.

Terminated Wrong potency / content Pfizer Inc. NDC 0008-0923-51 D-0516-2017
Class II · Moderate risk

Ondansetron Tablets USP

Failed Impurities/Degradation Specifications; 12 month stability time point

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 56111-153-30 D-0841-2016
Class III · Low risk

Ranitidine Syrup

Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.

Terminated Impurity / degradation Bio-pharm, Inc. NDC 23155-291-51 D-0809-2016
Class III · Low risk

Ranitidine Syrup

Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.

Terminated Stability / shelf life Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals D-0162-2016
Class II · Moderate risk

NEXIUM¿ (esomeprazole magnesium)

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.

Terminated Particulate / foreign matter AstraZeneca Pharmaceuticals LP NDC 00186-5020-31 D-1141-2015
Class II · Moderate risk

Famotidine tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-172-11 D-1225-2015
Class II · Moderate risk

Tpn 3:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1161-2015
Class II · Moderate risk

Tpn 3:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1159-2015